The long-term potential of the life sciences sector remains materially unchanged since 2021 – and it's in a new age of innovation, according to Travis McCready, head of life sciences, JLL's Americas Markets.
In its 2022 Life Sciences Research Outlook & Cluster Rankings, JLL said it believes that short-term challenges are just a temporary blip on the long-term path of growth because the world relishes novel therapies, innovative new modalities, increased adoption of advanced technologies and has an "insatiable demand for health and wellness that will drive the investment and growth forward for the foreseeable future."
JLL lists Boston, San Francisco and San Diego as its three most promising life sciences markets, respectively.
Continue Reading for Free
Register and gain access to:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
*May exclude premium content
Already have an account?
Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
